|
Year of Diagnosis |
Total | In Situ | Localized | Regional | Distant | Unknown | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Number | Percent | Number | Percent | Number | Percent | Number | Percent | Number | Percent | ||
| 2016-2020 | 362 | - | - | 230 | 63.5 | 60 | 16.6 | 32 | 8.8 | 40 | 11.0 |
| 2015-2019 | 348 | - | - | 217 | 62.4 | 48 | 13.8 | 30 | 8.6 | 53 | 15.2 |
| 2014-2018 | 337 | - | - | 205 | 60.8 | 47 | 13.9 | 27 | 8.0 | 58 | 17.2 |
| 2013-2017 | 336 | - | - | 204 | 60.7 | 48 | 14.3 | 24 | 7.1 | 60 | 17.9 |
| 2012-2016 | 340 | - | - | 215 | 63.2 | 48 | 14.1 | 18 | 5.3 | 59 | 17.4 |
| 2011-2015 | 350 | - | - | 220 | 62.9 | 54 | 15.4 | 20 | 5.7 | 56 | 16.0 |
| 2010-2014 | 362 | - | - | 230 | 63.5 | 60 | 16.6 | 20 | 5.5 | 52 | 14.4 |
| 2009-2013 | 371 | - | - | 227 | 61.2 | 64 | 17.3 | 18 | 4.9 | 62 | 16.7 |
| 2008-2012 | 374 | - | - | 225 | 60.2 | 64 | 17.1 | 14 | 3.7 | 71 | 19.0 |
| 2007-2011 | 387 | - | - | 238 | 61.5 | 61 | 15.8 | 13 | 3.4 | 75 | 19.4 |
| 2006-2010 | 380 | - | - | 239 | 62.9 | 53 | 13.9 | 12 | 3.2 | 76 | 20.0 |
| 2005-2009 | 378 | 1 | 0.3 | 243 | 64.3 | 47 | 12.4 | 8 | 2.1 | 79 | 20.9 |
| 2004-2008 | 360 | 1 | 0.3 | 240 | 66.7 | 42 | 11.7 | 7 | 1.9 | 70 | 19.4 |
| 2003-2007 | 334 | 2 | 0.6 | 226 | 67.7 | 34 | 10.2 | 7 | 2.1 | 65 | 19.5 |
| 2002-2006 | 300 | 3 | 1.0 | 202 | 67.3 | 31 | 10.3 | 6 | 2.0 | 58 | 19.3 |
| 2001-2005 | 291 | 3 | 1.0 | 198 | 68.0 | 29 | 10.0 | 3 | 1.0 | 58 | 19.9 |
| 2000-2004 | 276 | 3 | 1.1 | 186 | 67.4 | 25 | 9.1 | 7 | 2.5 | 55 | 19.9 |
| 1999-2003 | 265 | 3 | 1.1 | 179 | 67.5 | 24 | 9.1 | 7 | 2.6 | 52 | 19.6 |
| 1998-2002 | 260 | 2 | 0.8 | 175 | 67.3 | 21 | 8.1 | 10 | 3.8 | 52 | 20.0 |
| 1997-2001 | 259 | 1 | 0.4 | 168 | 64.9 | 25 | 9.7 | 12 | 4.6 | 53 | 20.5 |
| 1996-2000 | 240 | 1 | 0.4 | 155 | 64.6 | 28 | 11.7 | 12 | 5.0 | 44 | 18.3 |
| 1995-1999 | 224 | - | - | 146 | 65.2 | 27 | 12.1 | 8 | 3.6 | 43 | 19.2 |
| 1994-1998 | 239 | - | - | 147 | 61.5 | 29 | 12.1 | 9 | 3.8 | 54 | 22.6 |
| 1993-1997 | 246 | 1 | 0.4 | 145 | 58.9 | 37 | 15.0 | 7 | 2.8 | 56 | 22.8 |
| 1992-1996 | 252 | 1 | 0.4 | 151 | 59.9 | 36 | 14.3 | 8 | 3.2 | 56 | 22.2 |
| 1991-1995 | 251 | 1 | 0.4 | 145 | 57.8 | 34 | 13.5 | 11 | 4.4 | 60 | 23.9 |
| 1990-1994 | 245 | 2 | 0.8 | 139 | 56.7 | 34 | 13.9 | 15 | 6.1 | 55 | 22.4 |
| 1989-1993 | 225 | 2 | 0.9 | 124 | 55.1 | 35 | 15.6 | 19 | 8.4 | 45 | 20.0 |
| 1988-1992 | 206 | 3 | 1.5 | 111 | 53.9 | 29 | 14.1 | 21 | 10.2 | 42 | 20.4 |
| 1987-1991 | 189 | 3 | 1.6 | 89 | 47.1 | 23 | 12.2 | 20 | 10.6 | 54 | 28.6 |
| 1986-1990 | 172 | 3 | 1.7 | 74 | 43.0 | 22 | 12.8 | 18 | 10.5 | 55 | 32.0 |
| 1985-1989 | 183 | 3 | 1.6 | 68 | 37.2 | 25 | 13.7 | 20 | 10.9 | 67 | 36.6 |
| Notes: |
|---|
|
In Situ Stage represents the presence of malignant cells within the cell group from which they arose, with no penetration of basement membrane of the tissue and no stromal invasion. |
| Localized Stage represents invasive cancer confined to the organ of origin or intralumenal extension where specified as an intralumenal extension to immediately contiguous segments of the large bowel. |
| Regional Stage represents direct extension to adjacent organs or tissues or involvement of the regional lymph nodes. |
| Distant Stage represents direct continuity to non-adjacent organs, discontinuous metastasis or involvement of the distant lymph nodes. |
| COVID-19 Pandemic: In 2020, the highly publicized impact of the COVID-19 pandemic on health services and the consequential delays and reductions in cancer screening and diagnosis led to a decline in the 2020 incidence rates for most cancer sites. Because 2020 was a temporary, anomalous year, it can bias estimates such as cancer incidence trends. |
| Source : Michigan Resident Cancer Incidence File. Updated with cases processed through November 30, 2022. Division for Vital Records & Health Statistics, Michigan Department of Health & Human Services. |
|
Last Updated : April 13, 2023 |